![]() “We are privileged to welcome two members with highly relevant backgrounds to HeartBeam’s Board,” said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder. ![]() He is a Trustee for New Roads School and Big Bear Foundation and serves on the Board of Advisors of John Hopkins Medical Center. He serves as Member of Advisory Board at Global Analytics, Inc. He has served as a Director at Endurance Ventures, National Water and Power, Eco-Duro Corporation, NWP Services Corporation and Mobil Satellite Ventures. Strome has been a member of the Board of Directors of multiple companies over the last three decades. These include Pulse Biosciences, and iWood Studios, a company that creates original content for film and TV. He has also been involved in the founding and incubation of numerous publicly traded companies and several successful private companies. Previously, he was a Portfolio Manager at Kayne Anderson. Strome’s investment management company has managed private placement hedge fund investments focusing on non-traditional investments including commodities, currencies, bankruptcy reorganizations, and numerous venture capital and private equity investments. Strome is the Founder, Chief Investment Officer, and Chairman at Strome Investment Management, L.P. Mark Strome, 66, combines over 40 years of experience in the investment management and securities industry. In addition, he serves as Chairman of the Board for CardiaCare, and is an active board member in a handful of other disruptive cardiac digital health and medtech startups. Nelson currently serves as partner in the Medtech Advantage Fund, which has an exclusive partnership with Medtech Innovator, the largest medtech and digital health startup accelerator globally. Most recently, he served as Head of Digital Health, Diagnostics, and Monitoring for Biotronik, a leading cardiac digital health and medical device company. Nelson has led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries for three of the top four market share players in cardiac digital health and remote patient monitoring including BioTelemetry as VP of Sales, iRhythm as VP of Sales & Marketing, and Bardy Diagnostics as Chief Commercial Officer. Ken Nelson, 48, is a 20-year digital health, medical device, and remote patient monitoring executive and innovator. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced the appointment of Ken Nelson and Mark Strome to its board of directors, effective as of June 5, 2023. Accomplished Medical Technology Leader and Veteran Investor Bring Strategic Experience and Vision to Board ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |